Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
East Shines Over West? US Rejection Puts Roxadustat's China Approval In New Spotlight
Japan, EU Offer Other Growth Alternatives?
Aug 12 2021
•
By
Brian Yang
FIBROGEN'S ROXADUSTAT REJECTED IN US BUT CHINA, JAPAN, EU PRESENT OTHER OPPORTUNITIES • Source: Alamy
More from China
More from Focus On Asia